GLP-3R 30MG Lyophilized Vial – Mode Peptides
GLP-3R (Retatrutide analog) is a triple-agonist peptide targeting GLP-1, GIP, and Glucagon receptors. Designed for research on appetite suppression, glycemic control, and energy expenditure, it represents the next evolution beyond single and dual incretin agonists. Supplied as 30MG lyophilized powder.
Specs: 30MG | Purity 99%
For Research Purposes Only. Not for human or animal consumption.
$189.99 Original price was: $189.99.$140.27Current price is: $140.27.

Today
Today
3 - 7 Days
$139.99 Original price was: $139.99.$104.73Current price is: $104.73.
Mode Peptides GLP-3R 30MG provides a next-generation triple-agonist research peptide as a high-purity lyophilized powder for advanced metabolic research. Additionally, its research-focused formulation supports controlled laboratory investigations into metabolic signaling and receptor activity. Furthermore, researchers can evaluate the material in appropriate experimental models and established laboratory protocols.
GLP-3R 30MG is a synthetic peptide that researchers designed to simultaneously target three key incretin and glucagon pathways: Glucagon-Like Peptide-1 (GLP-1), Glucose-Dependent Insulinotropic Polypeptide (GIP), and Glucagon Receptor (GCGR).
This triple-agonist mechanism represents the latest evolution in incretin-based research, building on single-agonist (Semaglutide) and dual-agonist (Tirzepatide) models. Furthermore, by combining appetite suppression, enhanced glycemic control, and increased energy expenditure within one molecule, GLP-3R has become a major focus of contemporary research on obesity, type 2 diabetes, and metabolic syndrome. Currently, researchers investigate this compound under the research code Retatrutide.
Additionally, the lyophilized format supports stability and helps researchers maintain sample integrity under appropriate laboratory conditions. As a result, researchers can use the format for controlled reconstitution and experimental protocols that require consistent sample handling.
Researchers use GLP-3R 30MG in laboratory models to study tri-receptor agonism and metabolic regulation, glucose-dependent insulin secretion and beta-cell function, delayed gastric emptying and satiety signaling, appetite suppression and food intake reduction, energy expenditure and fatty acid oxidation through glucagon agonism, weight management and adiposity reduction, non-alcoholic fatty liver disease (NAFLD) and liver fat content, and cardiovascular and renal metabolic parameters. Additionally, researchers use this compound to compare efficacy and receptor-binding affinity with single and dual agonists, map downstream signaling pathways of GIPR, GLP-1R, and GCGR activation, and evaluate synergistic effects on body composition and glycemic control in diet-induced obesity models. Furthermore, these applications help researchers examine the interactions between multiple metabolic signaling pathways in controlled experimental settings.
Each batch includes a Certificate of Analysis (COA). For proper storage, keep the unreconstituted material at -20°C in a dry environment protected from light. After reconstitution, store the material at 2–8°C and follow established laboratory protocols for handling and use. Additionally, avoid repeated freeze-thaw cycles to help maintain sample integrity. For research use only.
The GLP-3R 30mg Research Product is intended exclusively for controlled laboratory and scientific research. Researchers may study GLP-3R in experimental models involving peptide biology, receptor signaling, metabolic pathways, cellular processes, and related biochemical mechanisms. For research use only, this material is not intended for human use, animal use, self-administration, diagnosis, treatment, cure, or prevention of any disease or medical condition. Qualified laboratory personnel should handle and evaluate the material according to established research protocols, institutional requirements, and applicable laboratory safety procedures.
Documentation, not promises.
Rarely
Sometimes
X
X
Varies